Shares of medical equipment maker Poly Medicure
rose 6 per cent to hit a new high of Rs 689 on the BSE in Friday’s intra-day trade after the company successfully raised Rs 400 crore through qualified institutional placement (QIP) route. In the past one week, the stock has rallied 16 per cent, as compared to a nearly 1 per cent decline in the S&P BSE Sensex.
opened on February 15, 2021, and closed on February I 8, 2021,” Poly Medicure
said in a regulatory filing.
On Thursday, the company’s QIP
committee approved the allotment of 7.63 million equity shares to eligible qualified institutional buyers at a price of Rs 524 per equity share, including a premium of Rs 519 per share, which was at a discount of Rs 26.79 (4.86 per cent to the floor price of Rs 550.79 per share), it said.
The company proposed to utilise the net proceeds for funding suitable organic and inorganic growth opportunities, ongoing capital expenditure, other long term and short terms requirements, pre-payment and/or repayment of outstanding borrowings and general corporate purpose.
is among the top five companies in the medical devices industry in India, in terms of operating income and profitability margin performance, in fiscal 2019.
The company manufactures and supplies, in India and internationally, a diverse portfolio of medical devices in the product verticals of infusion therapy, oncology, anaesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others.
The management said as an established player of significant scale, Polymed is set to benefit from the various tailwinds in the Indian market. Polymed’s strong pipeline is key to further profitably. The high brand equity and existing customer and distributor relationships are key for tapping into emerging growth opportunities, the company said in a presentation.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.